Are the PCSK9 Inhibitors the Panacea of Atherosclerosis Treatment? Effects on Lipid Lowering and Beyond - Evan Stein

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Are the PCSK9 Inhibitors the Panacea of Atherosclerosis Treatment? Effects on Lipid Lowering and Beyond - Evan Stein  at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Physicians with an interest in Cardiovascular Innovations

Learning Objectives

Loading Simple Education